DrugPatentWatch Database Preview
Mylan Pharms Inc Company Profile
What is the competitive landscape for MYLAN PHARMS INC, and when can generic versions of MYLAN PHARMS INC drugs launch?
There are eleven US patents protecting MYLAN PHARMS INC drugs. There are twenty-nine tentative approvals on MYLAN PHARMS INC drugs.
There are one hundred and ninety-one patent family members on MYLAN PHARMS INC drugs in thirty-nine countries and four hundred and thirteen supplementary protection certificates in thirteen countries.
Summary for Mylan Pharms Inc
| International Patents: | 191 |
| US Patents: | 11 |
| Tradenames: | 198 |
| Ingredients: | 188 |
| NDAs: | 242 |
Drugs and US Patents for Mylan Pharms Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mylan Pharms Inc | AVITA | tretinoin | CREAM;TOPICAL | 020404-003 | Jan 14, 1997 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Mylan Pharms Inc | FLUVASTATIN SODIUM | fluvastatin sodium | TABLET, EXTENDED RELEASE;ORAL | 202458-001 | Sep 11, 2015 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Mylan Pharms Inc | DIDANOSINE | didanosine | CAPSULE, DELAYED REL PELLETS;ORAL | 090788-001 | Apr 8, 2010 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| Mylan Pharms Inc | ERYGEL | erythromycin | GEL;TOPICAL | 050617-001 | Oct 21, 1987 | AT | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for Mylan Pharms Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Mylan Pharms Inc | OLUX | clobetasol propionate | AEROSOL, FOAM;TOPICAL | 021142-001 | May 26, 2000 | 6,126,920 | ➤ Sign Up |
| Mylan Pharms Inc | ZOVIRAX | acyclovir | CAPSULE;ORAL | 018828-001 | Jan 25, 1985 | 4,199,574 | ➤ Sign Up |
| Mylan Pharms Inc | AVITA | tretinoin | CREAM;TOPICAL | 020404-003 | Jan 14, 1997 | 4,971,800 | ➤ Sign Up |
| Mylan Pharms Inc | ZONALON | doxepin hydrochloride | CREAM;TOPICAL | 020126-001 | Apr 1, 1994 | 4,395,420 | ➤ Sign Up |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
Paragraph IV (Patent) Challenges for MYLAN PHARMS INC drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Foam | 0.12% | ➤ Subscribe | 2007-08-10 |
| ➤ Subscribe | Foam | 2% | ➤ Subscribe | 2009-07-30 |
| ➤ Subscribe | Topical Foam | 0.05% | ➤ Subscribe | 2005-06-27 |
Non-Orange Book US Patents for Mylan Pharms Inc
For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.
The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.
| Patent No. | Title | Estimated Patent Expiration |
|---|---|---|
| 5,250,688 | Purine derivatives | ➤ Sign Up |
| 5,684,153 | Process for the preparation of purine derivatives | ➤ Sign Up |
| 5,886,215 | 2-acetoxymethyl-4-halo-butyl-1-yl acetates | ➤ Sign Up |
| 5,075,445 | Guanine derivatives | ➤ Sign Up |
| Patent No. | Title | Estimated Patent Expiration |
International Patents for Mylan Pharms Inc Drugs
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Singapore | 114493 | ➤ Sign Up |
| Germany | 69122229 | ➤ Sign Up |
| Germany | 3582399 | ➤ Sign Up |
| World Intellectual Property Organization (WIPO) | 9920250 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for Mylan Pharms Inc Drugs
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 330 | Luxembourg | ➤ Sign Up | CERTIFICATE TITLE: UNE COMBINAISON D'OLMESARTAN MEDOXOMIL, OPTIONNELLEMENT SOUS LA FORME D'UN SEL PHARMACEUTIQUEMENT ACCEPTABLE ET D'HYDROCHLOROTHIAZIDE (OLMETEC PLUS) |
| 00086 | Netherlands | ➤ Sign Up | PRODUCT NAME: IMATINIB, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZUURADDITIEZOUT, IN HET BIJZONDER HET MESILAAT; NATL. REGISTRATION NO/DATE: EU/1/01/198/001 - 006 20011107; FIRST REGISTRATION: CH IKS 55807 20010621 |
| C/GB05/042 | United Kingdom | ➤ Sign Up | PRODUCT NAME: MESYLATE, ESYLATE OR SULFATE SALTS OF N-PROPARGYL-1(R)-AMINOINDAN (RASAGILINE); REGISTERED: UK EU/1/04/304/001 20050221; UK EU/1/04/304/002 20050221; UK EU/1/04/304/003 20050221; UK EU/1/04/304/004 20050221; UK EU/1/04/304/005 20050221; UK EU/1/04/304/006 20050221; UK EU/1/04/304/007 20050221 |
| 00357 | Netherlands | ➤ Sign Up | PRODUCT NAME: SITAGLIPTINE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVA ARDBAAR ZOUT, IN HET BIJZONDER HET MONOFOSFAAT, EN METFORMINE DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, IN HET BIJZONDER HET HYDROCHLORIDE; REGISTRATION NO/DATE: EU/1/08/455/001-014 20080716 |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
